Observational studyMedicine2019

Statin therapy and erythropoiesis-stimulating agent hyporesponsiveness in patients with nondialysis chronic kidney disease: A retrospective study in Beijing, China.

Zhun Sui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.